Results

Total Results: 316 records

Showing results for "vascular".

  1. www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-myocardial-infarction-preventive-medication-1996
    January 01, 1996 - Collaboration Collaborative overview of randomised trials of antiplatelet therapy—II: maintenance of vascular … Anti-Platelet Trialists' Collaboration Secondary prevention of vascular disease by prolonged antiplatelet
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/DCfAJZvNDzSYu7NqLJX2bv
    March 01, 2016 - Random-effects meta-analysis was used to estimate the relative and absolute benefits of vascular endothelial … AMD indicates age-related macular degeneration; VEGF, vascular endothelial growth factor. … VEGF indicates vascular endothelial growth factor. Figure 3. … VEGF indicates vascular endothelial growth factor. … Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related
  3. www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-screening-using-nontraditional-risk-assessment
    July 10, 2018 - Potential Preventable Burden Cardiovascular disease comprises diseases of the heart and vascular system … The Viborg Vascular (VIVA) screening trial 30 recently reported interim results; this trial randomized … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. … Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/s9Hht_QpMB4gQg26rTpcaN
    November 01, 2013 - Aspirin for vascular dementia. Cochrane Database Syst Rev. 2000:CD001296. [PMID: 11034710] 14. … Donepezil in vascular dementia: a random- ized, placebo-controlled study. … Galantamine treatment of vascular dementia: a randomized trial. Neurology. 2007;69:448-58. … Rivastigmine in Chinese patients with subcortical vascular dementia. … The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
  5. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/atrial-fibrillation-screening-with-electrocardiography-august-2018
    July 14, 2016 - In response to comments, the USPSTF replaced the term “cerebral vascular accident” with “stroke,” “cardioembolic
  6. www.uspreventiveservicestaskforce.org/Home/GetFileByID/1862
    August 01, 2014 - and Pregnant Women (April 2009) Click Here to Learn More About Cardiovascular Disease Heart and Vascular
  7. www.uspreventiveservicestaskforce.org/home/getfilebytoken/rhSzEVBjRK5CW8G42VWuVU
    August 01, 2014 - and Pregnant Women (April 2009) Click Here to Learn More About Cardiovascular Disease Heart and Vascular
  8. www.uspreventiveservicestaskforce.org/uspstf/recommendation/impaired-visual-acuity-in-older-adults-screening-2016
    March 01, 2016 - AMD = age-related macular degeneration; VEGF = vascular endothelial growth factor. … CI, 0.87–16]) (3 trials). 4 , 5 One of 2 trials found that treatment of wet AMD with intravitreal vascular … Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related
  9. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary16/coronary-heart-disease-screening-using-non-traditional-risk-factors
    October 15, 2009 - Endorsed by the Society for Vascular Medicine. … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. … Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective … Presence of calcified carotid plaque predicts vascular events: the Northern Manhattan Study. … Is C-reactive protein specific for vascular disease in women? Ann Intern Med . 2002;136:529-33.
  10. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary16/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
    October 15, 2009 - Endorsed by the Society for Vascular Medicine. … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. … Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective … Presence of calcified carotid plaque predicts vascular events: the Northern Manhattan Study. … Is C-reactive protein specific for vascular disease in women? Ann Intern Med . 2002;136:529-33.
  11. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary50/impaired-visual-acuity-in-older-adults-screening1
    July 15, 2009 - cataracts; antioxidants or vitamins for dry AMD; and laser photocoagulation, photodynamic therapy, and vascular … Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors. … acuity loss of about 2.5. 65 , 66 In 1 of the trials, results were sustained through 24 months. 66 Vascular … Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors. … Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related
  12. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary50/impaired-visual-acuity-in-older-adults-screening-2009
    July 15, 2009 - cataracts; antioxidants or vitamins for dry AMD; and laser photocoagulation, photodynamic therapy, and vascular … Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors. … acuity loss of about 2.5. 65 , 66 In 1 of the trials, results were sustained through 24 months. 66 Vascular … Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors. … Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related
  13. www.uspreventiveservicestaskforce.org/home/getfilebytoken/8JYDupJfG6LdRn7A6FkqXX
    March 01, 2016 - [95% CI, 0.87-16]) (3 trials).4,5 One of 2 trials found that treatment of wet AMD with intravitreal vascular … AMD indicates age-related macular degeneration; VEGF, vascular endothelial growth factor. … Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related
  14. www.uspreventiveservicestaskforce.org/home/getfilebytoken/6cRgd5whkAvSGESSQsrQLR
    January 01, 2020 - Potential Preventable Burden Cardiovascular disease comprises diseases of the heart and vascular system … The Viborg Vascular (VIVA) screening trial30 recently re- ported interim results; this trial randomized … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. … Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled
  15. www.uspreventiveservicestaskforce.org/home/getfilebytoken/ATw4mRze5EGYVYWwuYrvej
    February 01, 2014 - Department of Health and Human Services) Heart and Vascular Disease (National Heart, Lung, and
  16. www.uspreventiveservicestaskforce.org/home/getfilebytoken/whbbEX529Ha4FyvsYv6uh6
    April 26, 2022 - trials—A Study of Cardiovas- cular Events in Diabetes (ASCEND), Aspirin to Reduce Risk of Ini- tial Vascular … Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular … Aspirin for stroke prevention in elderly patients with vascular risk factors: Japanese Primary Prevention … Effect of low-dose aspirin on functional outcome from cerebral vascular events in women. … Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/2GDCmTe7akyrAHsTMbfz72
    May 06, 2022 - Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular … Aspirin for stroke prevention in elderly patients with vascular risk factors: Japanese Primary Prevention … Effect of low-dose aspirin on functional outcome from cerebral vascular events in women. … Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects … Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis
  18. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary23/diabetes-mellitus-type-2-in-adults-screening-2008
    June 15, 2008 - tight glycemic control resulted in a modest reduction of macrovascular events, particularly peripheral vascular … events (relative risk reduction, 27% [CI, 7% to 40%]) as did persons without diabetes who had known vascular … Collaborative meta-analysis showed a nonsignificant 7% relative risk reduction in the incidence of vascular … models, all predicted that delaying the onset of diabetes would substantially reduce the incidence of vascular … Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
  19. www.uspreventiveservicestaskforce.org/home/getfilebytoken/JcwfLrEqaaxP6DPEQvxgUs
    February 18, 2020 - Medical Expenditure Panel Survey, which did allow for the differentiation of individuals with and without vascular … disease (defined as coronary heart disease, stroke, or peripheral vascular dis- ease), found that the … assess the balance of benefits and harms of initiating statin use for the primary prevention of cardio- vascular … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. … The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease
  20. www.uspreventiveservicestaskforce.org/uspstf/recommendation/abnormal-blood-glucose-type-2-diabetes-mellitus-screening-1996
    January 01, 1996 - with diabetes are at significantly increased risk for coronary heart disease, stroke, and peripheral vascular … but not in those with NIDDM, 81 and there was no correlation between cerebrovascular and peripheral vascular … Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. … macrovascular disease in diabetes mellitus: the London follow-up to the WHO multinational study of vascular

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: